Heart Valve Technology

This channel includes news and new device innovations about heart valve technologies, including the aortic valve, mitral valve, pulmonic valve, and tricuspid valve. This includes information on transcatheter valve technologies like transcatheter aortic valve replacement (TAVR, or implantation TAVI), transcatheter mitral valve replacement (TMVR), transcatheter and surgical valve repairs, ad surgical replacement valves.

Medtronic Launches Evolut Pro+ TAVR System
Technology | Heart Valve Technology | September 24, 2019

September 24, 2019 – Medtronic announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of the...

Abbott Receives European CE Mark for Two Pediatric Heart Devices
News | Congenital Heart | September 20, 2019

September 20, 2019 – Abbott announced approvals in Europe for two of its pediatric devices — the Masters HP 15mm...

New Research on Tempo Temporary Pacing Lead to Be Featured at TCT 2019
News | Leads Implantable Devices | September 20, 2019

September 20, 2019 — BioTrace Medical Inc. announced the company’s key activities at the 31st annual...

Reducing Secondary Mitral Regurgitation in Heart Failure Does Not Improve Two-year Outcomes
News | Heart Valve Technology | September 11, 2019

September 11, 2019 — Percutaneous reduction of...

Abbott Launches Pivotal Trial of TriClip Tricuspid Valve Repair System
News | Heart Valve Technology | September 05, 2019

September 5, 2019 — Abbott announced the launch of the company's TRILUMINATE Pivotal trial evaluating the safety and...

The most popular cardiac technology news in August 2019 was the FDA clearance for a new indication for both the Edwards Sapien 3 and Medtronic CoreValve transcatheter aortic valve replacement (TAVR) devices for low-risk patients. This puts the technology on equal footing with the previous standard-of-care of open heart surgery, representing a paradigm shift in cardiology.

The most popular cardiac technology news in August 2019 was the FDA clearance for a new indication for both the Edwards Sapien 3 and Medtronic CoreValve transcatheter aortic valve replacement (TAVR) devices for low-risk patients. This puts the technology on equal footing with the previous standard-of-care of open heart surgery, representing a paradigm shift in cardiology. 

Feature | September 03, 2019 | Dave Fornell, Editor

September 3, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (...

An illustration of the BASILICA procedure showing the leaflet of the original bioprosthetic valve sliced open to allow coronary blood flow after implantation of a TAVR valve. The new TAVR valve can push the leaflets of the bioprosthetic valve upwards, blocking the coronary arteries. During the BASILICA procedure, a catheter directs an electrified guidewire through the base of the left aortic cusp into a snare in the left ventricular outflow tract (LVOT). After snare retrieval, the mid-shaft of the guidewire

An illustration of the BASILICA procedure showing the leaflet of the original bioprosthetic valve sliced open to allow coronary blood flow after implantation of a TAVR valve. The new TAVR valve can push the leaflets of the bioprosthetic valve upwards, blocking the coronary arteries. During the BASILICA procedure, a catheter directs an electrified guidewire through the base of the left aortic cusp into a snare in the left ventricular outflow tract (LVOT). After snare retrieval, the mid-shaft of the guidewire is electrified to lacerate the leaflet, and the the leaflet splays after TAVR permitting coronary flow.

Feature | Heart Valve Technology | August 27, 2019

A novel technique has proven successful in preventing coronary artery obstruction during transcatheter aortic valve...

Edwards Recalls Sapien 3 Ultra Delivery System Due to Burst Balloons During Surgery
News | Heart Valve Technology | August 22, 2019

August 22, 2019 — Edwards Lifesciences is recalling the Sapien 3 Ultra...

Experts Caution Against Catch-all Assumptions About LVADs and Mitral Regurgitation

Paul Tang, M.D., Ph.D., a cardiac surgeon at Michigan Medicine’s Frankel Cardiovascular Center in the OR. Image courtesy of Michigan Medicine.

News | Ventricular Assist Devices (VAD) | August 20, 2019

August 20, 2019 — Left...

FDA Approves Sapien 3, CoreValve Evolut TAVR Valves for Low-risk Patients

Left, an illustration of the beginning of deployment for a CoreValve Evolut self-expanding transcatheter aortic replacement (TAVR) valve. Right, an illustration of the final balloon expansion of an Edwards Lifesciences Sapien 3 TAVR valve. Both valves received simultaneous FDA clearance for use in low-risk surgical patients. Clearing this last hurdle now allows wide-spread use of minimally invasive TAVR in all patients who otherwise would need an open-heart surgical valve replacement. 

Feature | Heart Valve Technology | August 16, 2019 | Jeff Zagoudis, Associate Editor, and Dave Fornell, Editor

August 16, 2019 — In one coordinated move, the U.S. Food and Drug Administration (FDA) opened use of ...

Example of an aortic valve CT imaging workup for TAVR valve sizing and assessing access routes. This patient has an aneurysm in the aortic arch. Image from GE Healthcare.

Example of an aortic valve CT imaging workup for TAVR valve sizing and assessing access routes. This patient has an aneurysm in the aortic arch. Image from GE Healthcare.

Feature | Structural Heart | August 12, 2019 | Ashish Pershad, M.D., and Kenith Fang, M.D., FACS

As we usher in a new era for treating patients with aortic stenosis, we have been reflecting on the evolution of the...

Filterlex Medical Raises $3 Million in Series A Financing for Embolic Protection Device
News | Embolic Protection Devices | July 19, 2019

July 19, 2019 — Medical device startup company Filterlex Medical recently completed a series A financing round,...

Overlay Init